(Q33571828)

28 July 2017

1 reference

title

Selective versus nonselective beta adrenoceptor antagonists in hypertension (English)

1 reference

28 July 2017

Van Bortel LM

1

1 reference

28 July 2017

Ament AJ

series ordinal

2

1 reference

28 July 2017

publication date

1 December 1995

1 reference

28 July 2017

1 reference

28 July 2017

volume

8

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

513-523

1 reference

Quality of life and its impact on hypertensive patients.

28 July 2017

cites work

1 reference

12 December 2020

Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study

1 reference

12 December 2020

Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol.

1 reference

12 December 2020

Hypertensive renal damage

1 reference

12 December 2020

Effect of antihypertensives on sexual function and quality of life: the TAIM Study

1 reference

12 December 2020

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

12 December 2020

The costs of treating hypertension in Sweden. An empirical investigation in primary health care

1 reference

12 December 2020

The beta-receptor, atheroma and cardiovascular damage

1 reference

12 December 2020

Comparison of enalapril and atenolol in mild to moderate hypertension

1 reference

12 December 2020

Screening for noncompliance among patients with hypertension: is self-report the best available measure?

1 reference

12 December 2020

The influence of beta blockers on cardiovascular reactivity and Type A behavior pattern in hypertensives

1 reference

12 December 2020

The quality of life, research, and care

1 reference

12 December 2020

Principles of cost-effective resource allocation in health care organizations

1 reference

12 December 2020

Beta-adrenergic blockers.

1 reference

12 December 2020

Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol

1 reference

12 December 2020

European Infarction Study (E.I.S.). A secondary prevention study with slow release oxprenolol after myocardial infarction: morbidity and mortality

1 reference

12 December 2020

Management of patient compliance in the treatment of hypertension. Report of the NHLBI Working Group

1 reference

12 December 2020

The effects of antihypertensive therapy on the quality of life

1 reference

12 December 2020

Can simple clinical measurements detect patient noncompliance?

1 reference

12 December 2020

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

12 December 2020

Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension

1 reference

12 December 2020

A review of cost-effectiveness analyses of hypertension treatment

1 reference

12 December 2020

By what means might beta blockers prolong life after acute myocardial infarction?

1 reference

12 December 2020

Progress in the 1980s and new directions in the 1990s with hypertension management. From the stepped-care approach to the individualised programme in hypertension treatment and control

1 reference

12 December 2020

Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine

1 reference

12 December 2020

The survival of treated hypertensive patients and their causes of death: a report from the DHSS hypertensive care computing project (DHCCP)

1 reference

12 December 2020

Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life

1 reference

12 December 2020

The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives

1 reference

12 December 2020

The cost-effectiveness of treating mild-to-moderate hypertension: a reappraisal

1 reference

12 December 2020

Randomised trial of treatment of hypertension in elderly patients in primary care

1 reference

12 December 2020

Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus

1 reference

12 December 2020

Propranolol Medication among Coronary Patients: Relationship to Type a Behavior and Cardiovascular Response

1 reference

12 December 2020

Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group

1 reference

12 December 2020

Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Metabolic effects of antihypertensive drugs interacting with the sympathetic nervous system

1 reference

12 December 2020

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

12 December 2020

Quality of life after myocardial infarction: effect of long term metoprolol on mortality and morbidity

1 reference

12 December 2020

Quality of life perception during antihypertensive treatment: a comparative study of bisoprolol and enalapril

1 reference

12 December 2020

Reducing the risk for coronary heart disease and stroke in hypertensives--comments on mechanisms for coronary protection and quality of life

1 reference

12 December 2020

Antihypertensive therapy and cardiovascular risk. Are all antihypertensives equal?

1 reference

12 December 2020

Circadian variation in the frequency of onset of acute myocardial infarction

1 reference

12 December 2020

Pharmacoeconomic evaluation of risk factors for cardiovascular disease: an epidemiological perspective

1 reference

12 December 2020

Effects of 100 mg of controlled-release metoprolol and 100 mg of atenolol on blood pressure, central nervous system-related symptoms, and general well being

1 reference

12 December 2020

Blood pressure, stroke, and coronary heart disease

1 reference

12 December 2020

Economic issues relating to access to medications.

1 reference

12 December 2020

Primary prevention of stroke

1 reference

12 December 2020

Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol.

1 reference

12 December 2020

Reversal of atherosis and sclerosis. The two components of atherosclerosis

1 reference

12 December 2020

The persistent problem of poor blood pressure control

1 reference

12 December 2020

The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)

1 reference

12 December 2020

Outcome of blood pressure control

1 reference

12 December 2020

Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinations

1 reference

12 December 2020

Quality of life as a therapeutic end-point. An analysis of therapeutic trials in hypertension

1 reference

12 December 2020

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

1 reference

12 December 2020

Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence

1 reference

12 December 2020

Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project

1 reference

12 December 2020

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

12 December 2020

Long-term beta blockade: possible protection from myocardial infarction

1 reference

12 December 2020

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies

1 reference

12 December 2020

Mechanical and other factors relating to left ventricular hypertrophy.

1 reference

12 December 2020

Process versus outcome in hypertension: a positive result

1 reference

12 December 2020

The cost-effectiveness of treating hypertension in elderly people--an analysis of the Swedish Trial in Old Patients with Hypertension (STOP Hypertension)

1 reference

12 December 2020

Estimating costs in the economic evaluation of medical technologies

1 reference

12 December 2020

Quality of life and cost-effectiveness in the treatment of hypertension

1 reference

12 December 2020

Compliance characteristics of 291 hypertensive patients from a rural midwest area

1 reference

12 December 2020

Formulary considerations in selection of beta-blockers

1 reference

12 December 2020

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

12 December 2020

Quality of life in cardiovascular diseases. Emphasis on beta-blocker treatment

1 reference

12 December 2020

The effect of pindolol on the two years mortality after complicated myocardial infarction

1 reference

12 December 2020

The effect of prescribed daily dose frequency on patient medication compliance

1 reference

12 December 2020

Analysis of antihypertensive treatment outcome and stroke

1 reference

12 December 2020

Metabolic parameters: how important are pharmacologically-induced changes?

1 reference

12 December 2020

10.2165/00019053-199508060-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1003221331

0 references

Fatcat ID

release_wrzwrqxgnbhu3o764jks34iaci

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wrzwrqxgnbhu3o764jks34iaci

24 November 2022

mapped directly with Wikidata item

1 reference